Clinics and Practice https://www.clinicsandpractice.org/index.php/cp <p><strong>Clinics and Practice</strong> [ISSN 2039-7283] is a peer-reviewed, Open Access, online-only journal that publishes <em>clinical reports,</em> <em>brief reports</em>&nbsp;and&nbsp;<em>case reports</em>&nbsp;in all areas of clinical medicine. Our journal would welcome any interesting description of patients, procedures and treatment in any condition or disease that can contribute to develop scientifically rigorous and clinically meaningful practice methods. <br><strong>Clinics and Practice</strong> aims at creating an innovative, rapid and collaborative background intended to help healthcare professionals finding the latest advances to answer the most pressing questions coming from the medicine/patients relationship.</p> en-US <p><strong>PAGEPress</strong> has chosen to apply the&nbsp;<a href="http://creativecommons.org/licenses/by-nc/4.0/" target="_blank" rel="noopener"><strong>Creative Commons Attribution NonCommercial 4.0 International License</strong></a>&nbsp;(CC BY-NC 4.0) to all manuscripts to be published.<br><br> An Open Access Publication is one that meets the following two conditions:</p> <ol> <li class="show">the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.</li> <li class="show">a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.</li> </ol> <p>Authors who publish with this journal agree to the following terms:</p> <ol> <li class="show">Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.</li> <li class="show">Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.</li> <li class="show">Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.</li> </ol> paola.granata@pagepress.org (Paola Granata) tiziano.taccini@pagepress.org (Tiziano Taccini) Tue, 19 May 2020 13:12:47 +0000 OJS 3.1.2.4 http://blogs.law.harvard.edu/tech/rss 60 COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review https://www.clinicsandpractice.org/index.php/cp/article/view/1271 <p>Coronavirus disease-19 (COVID-19) has been regarded as an infective-inflammatory disease, which affects mainly lungs. More recently, a multi-organ involvement has been highlighted, with different pathways of injury. A hemoglobinopathy, hypoxia and cell iron overload might have a possible additional role. Scientific literature has pointed out two potential pathophysiological mechanisms: i) severe acute respiratory syndrome-coronavirus-2 (SARS-CoV- 2) interaction with hemoglobin molecule, through CD147, CD26 and other receptors located on erythrocyte and/or blood cell precursors; ii) hepcidin-mimetic action of a viral spike protein, inducing ferroportin blockage. In this translational medicine-based narrative review, the following pathologic metabolic pathways, deriving from hemoglobin denaturation and iron metabolism dysregulation, are highlighted: i) decrease of functioning hemoglobin quote; ii) iron overload in cell/tissue (hyperferritinemia); iii) release of free toxic circulating heme; iv) hypoxemia and systemic hypoxia; v) reduction of nitric oxide; vi) coagulation activation; vii) ferroptosis with oxidative stress and lipoperoxidation; viii) mitochondrial degeneration and apoptosis. A few clinical syndromes may follow, such as pulmonary edema based on arterial vasoconstriction and altered alveolo-capillary barrier, sideroblastic-like anemia, endotheliitis, vasospastic acrosyndrome, and arterio- venous thromboembolism. We speculated that in COVID-19, beyond the classical pulmonary immune-inflammation view, the occurrence of an oxygen-deprived blood disease, with iron metabolism dysregulation, should be taken in consideration. A more comprehensive diagnostic/therapeutic approach to COVID-19 is proposed, including potential adjuvant interventions aimed at improving hemoglobin dysfunction, iron over-deposit and generalized hypoxic state.</p> Attilio Cavezzi, Emidio Troiani, Salvatore Corrao Copyright (c) 2020 the Author(s) http://creativecommons.org/licenses/by-nc/4.0 https://www.clinicsandpractice.org/index.php/cp/article/view/1271 Thu, 28 May 2020 09:02:35 +0000 Severe immune thrombocytopenia induced by a single dose of nivolumab in a patient with advanced non-small cell lung cancer https://www.clinicsandpractice.org/index.php/cp/article/view/1249 <p>Nivolumab-induced immune thrombocytopenia (ITP) is a rare process with few reported cases. We present a 67-year-old man with advanced non-small cell lung cancer who was hospitalized with severe thrombocytopenia. Physical exam was notable for petechiae across his chest and extremities as well as bullae in his oral cavity. The patient initially received high-dose glucocorticoids and intravenous immuno - globulin, but did not respond to treatment. He was then started on weekly rituximab and after three doses, there was complete resolution of his thrombocytopenia. Altogether, his presentation was an extreme case and rare side effect of immune checkpoint therapy, known as nivolumab-induced ITP. Diagnosis of nivolumab-induced ITP is challenging given the lack of specific testing and a wide differential diagnosis. There are few cases reporting severe ITP following nivolumab treatment. We highlight the importance of recognizing and treating this rare complication of immunotherapy.</p> Adam Khorasanchi, Roger Keresztes Copyright (c) 2020 the Author(s) http://creativecommons.org/licenses/by-nc/4.0 https://www.clinicsandpractice.org/index.php/cp/article/view/1249 Wed, 17 Jun 2020 13:12:13 +0000 Keratinocyte dissociation (desmolysis/acantholysis) in ameloblastoma https://www.clinicsandpractice.org/index.php/cp/article/view/1255 <p>Ameloblastoma is the only odontogenic tumor that displays diversified histomorphological features with subtypes like follicular, plexiform, acanthomatous, granular cell, clear cell, desmoplastic etc. In this paper we presented an extremely unusual presentation of ameloblastoma, which is characterized by desmolysis or acantholysis of stellate reticulum-like cells caused due to keratinocyte dissociation. A 35-year-old male patient presented with a painless hard 3×3 cm swelling in the mandibular right posterior region in the past 4-5 months. Radiographic examination revealed a multilocular radiolucent lesion in the body of mandible with resorption of the roots. Histopathological examination revealed ameloblastic follicles with central cells showing keratinocyte dissociation leading to desmolysis/acantholysis. Desmolytic cells were seen as an isolated entity in the follicular space with round to polygonal shaped morphology. Future retrospective studies on archival samples of ameloblastoma are recommended to relook into identification of such rare phenomenon. This will help in better understanding of the incidence rate and biological behavior of this rare variant of ameloblastoma.</p> Sachin C. Sarode, Gargi S. Sarode, Praveen Birur, Yaser A. Alhazmi, Shankargouda Patil Copyright (c) 2020 the Author(s) http://creativecommons.org/licenses/by-nc/4.0 https://www.clinicsandpractice.org/index.php/cp/article/view/1255 Tue, 19 May 2020 13:08:50 +0000 Critical upper airway obstruction as the first symptom of acute myeloid leukemia - an anesthesiologic reminder https://www.clinicsandpractice.org/index.php/cp/article/view/1214 <p>Acute upper airway obstruction can be fatal. Early recognition of airway distress followed by diagnostic laryngoscopy and prompt intervention to secure airway control is crucial. We here present a 62-year old male patient who presented with cough and increasing respiratory distress for three weeks. Within the next 24 h, he developed symptoms of critical upper airway obstruction, endotracheal intubation was not possible, and an acute surgical tracheotomy was performed to retain patent airways. A computer tomography scan revealed severe laryngopharyngeal soft tissue thickening and upper airway obstruction caused by leukemic infiltration. He was diagnosed with acute leukemia and responded to induction chemotherapy. This case report points out the importance of establishing the diagnosis of critical upper airway obstruction in patients presenting with respiratory symptoms, and highlights the emergency management of airway obstruction due to malignant infiltration of leukemic blasts.</p> Øyvind Bruserud, Øystein Wendelbo, Nils Vetti, Frederik Kragerud Goplen, Silje Johansen, Håkon Reikvam Copyright (c) 2020 the Author(s) http://creativecommons.org/licenses/by-nc/4.0 https://www.clinicsandpractice.org/index.php/cp/article/view/1214 Wed, 10 Jun 2020 08:09:09 +0000 Synchronous occurrence of odontogenic keratocyst and ameloblastoma: A case report and review of the literature https://www.clinicsandpractice.org/index.php/cp/article/view/1205 <p>Odontogenic keratocyst (OKC) and ameloblastomas are distinct histopathologically diagnosed odontogenic lesions of the oral cavity. Both are primarily located in the posterior regions of the mandible, however, they can involve the maxilla as well. The occurrence of both an OKC and ameloblastoma in a patient is very uncommon. This case demonstrated such a lesion in the mandible of a 57 years old female. The diagnostic work-up and features of both lesions are illustrated with special focus on histopathological variances distinguishing OKC from ameloblastoma with the support of immunohistochemistry. This case highlights the importance of identifying accurate diagnoses for such lesions which may prompt clinical implications. Clinico-pathologic understanding of both lesions signifies the need for careful management plan and prevention of recurrence. Previously reported simultaneous occurrences of odontogenic cysts and/or tumors in the oral cavity are also reviewed.</p> Norman Firth, Abdulhameed Alsarraf, Nathan Vujcich, Omar Kujan Copyright (c) 2020 the Author(s) http://creativecommons.org/licenses/by-nc/4.0 https://www.clinicsandpractice.org/index.php/cp/article/view/1205 Mon, 22 Jun 2020 14:05:07 +0000 Brunner’s gland hyperplasia: A rare cause of gastrointestinal bleeding https://www.clinicsandpractice.org/index.php/cp/article/view/1267 <p>Brunner’s gland hyperplasia (BGH) is an unusual entity that presents with large duodenal polyp or mass and rarely causes gastrointestinal bleeding. It is usually asymptomatic and often an incidental finding during the esophagoduodenoscopy (EGD). However, most of the cases are benign. We encounter a 40 years old man who presented in Emergency Room with melena. EGD revealed solitary, large duodenal polyp in second part of duodenum and later histopathological findings were consistent with BGH.</p> Lubna Kamani, Ravi Raj, Rabia Ali, Faisal Siddiqi Copyright (c) 2020 the Author(s) http://creativecommons.org/licenses/by-nc/4.0 https://www.clinicsandpractice.org/index.php/cp/article/view/1267 Mon, 22 Jun 2020 14:18:04 +0000 Acute esophageal necrosis: A rare case of upper gastrointestinal bleeding from diabetic ketoacidosis https://www.clinicsandpractice.org/index.php/cp/article/view/1254 <p>Acute esophageal necrosis, also known as black esophagus or acute necrotizing esophagitis is a rare condition with roughly 154 cases reported in the literature. This condition is classically diagnosed on its endoscopic findings of a circumferentially black esophagus that abruptly ends at the gastroesophageal junction and transitions to normal gastric mucosa. When present, acute esophageal necrosis potentially signifies a poor prognosis with an overall mortality up to 36%. This case report describes a critically ill patient with multiple comorbidities that was found to have acute esophageal necrosis the entire length of the esophagus secondary to ischemia/hypoperfusion that was caused by diabetic ketoacidosis. The patient had a prolonged hospitalization but was ultimately discharged in stable condition. We also review the literature of this rare esophageal condition.</p> Dustin J. Uhlenhopp, Gregory Pagnotta, Tagore Sunkara Copyright (c) 2020 the Author(s) http://creativecommons.org/licenses/by-nc/4.0 https://www.clinicsandpractice.org/index.php/cp/article/view/1254 Mon, 29 Jun 2020 00:00:00 +0000 Immune mediated necrotizing myopathy: A rare complication of statin therapy https://www.clinicsandpractice.org/index.php/cp/article/view/1248 <p>Immune mediated necrotizing myopathy (IMNM) is part of the inflammatory myopathies group of diseases and presents with muscle weakness, myalgias and elevated serum creatine phosphokinase (CPK). Statin-induced IMNM is a rare complication. We present a patient with IMNM secondary to simvastatin use. The patient presented with proximal myopathy, dysphagia, and elevated creatinine kinase levels, and was subsequently found to have anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) autoantibodies with a necrotizing process on muscle biopsy. This patient’s case was further complicated by sequelae of multiple disease processes, ultimately leading to deterioration of his health.</p> Shady Piedra Abusharar, Prashanth Moku, Sharon Banks, Fahad M. Khalid, Charles S. Specht, Hyma V. Polimera Copyright (c) 2020 the Author(s) http://creativecommons.org/licenses/by-nc/4.0 https://www.clinicsandpractice.org/index.php/cp/article/view/1248 Tue, 30 Jun 2020 08:33:52 +0000